Skip to main content

COVID-19 Topic Center

FDA News Expert Insights

Pharmacy Learning Network
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…
Pharmacy Learning Network
By Julie Gould Tony Lin, PharmD, senior scientific director, AbbVie US medical affairs, discusses the VIALE-A (M15-656) and VIALE-C (M16-043) trials, which helped determine the approval of Venclexta for acute myeloid leukemia, and highlights what this approval means for clinical practice. Can you…
Pharmacy Learning Network
Benzodiazepines (BZs) are one of the most heavily prescribed medications. Since chlordiazepoxide was first approved in 1960, statistics on their use are staggering. From 1996 to 2013 the percentage of adults who filled a BZs prescription per year increased 30%. 1 In 2008, approximately 5.2% of…
Pharmacy Learning Network
Pfizer Inc. is recalling more than 19,000 vials of fentanyl citrate injection due to a lack of sterility assurance. The August 12, 2020, US Food and Drug Administration (FDA) Enforcement Report cites “potential loose metal overseal crimp defects.”  The recall affects fentanyl citrate injection,…
Back to Top